Testosterone Cypionate
Brands: Azmiro · Depo-Testosterone · Testosterone Cypionate
15 active makers
soon
soon
soon
soon
US acquisition costNADAC · per unit
Average across 25 priced NDCs. A benchmark of pharmacy acquisition cost - not a retail quote.
Brands: Azmiro · Depo-Testosterone · Testosterone Cypionate
Average across 25 priced NDCs. A benchmark of pharmacy acquisition cost - not a retail quote.
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume - Medicaid only, not all-payer.
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Asclemed USA, Inc. | repackager | 8 | SUPPLYING |
| Bryant Ranch Prepack | repackager | 7 | SUPPLYING |
| Pharmacia & Upjohn Company LLC | unknown | 5 | SUPPLYING |
| A-S Medication Solutions | repackager | 4 | SUPPLYING |
| Padagis US LLC | unknown | 4 | SUPPLYING |
| Xiromed, LLC | unknown | 3 | SUPPLYING |
| SUN PHARMACEUTICAL INDUSTRIES, INC. | generic | 3 | SUPPLYING |
| Eugia US LLC | generic | 3 | SUPPLYING |
| Hospira, Inc. | brand | 3 | SUPPLYING |
| Cipla USA Inc. | generic | 2 | SUPPLYING |
| NuCare Pharmaceuticals,Inc. | repackager | 2 | SUPPLYING |
| Azurity Pharmaceuticals, Inc. | unknown | 2 | SUPPLYING |
| Alvogen Inc. | unknown | 2 | SUPPLYING |
| NorthStar Rx LLC | relabeler | 1 | SUPPLYING |
| American Regent, Inc. | unknown | 1 | SUPPLYING |
Shortages, recalls, and registration changes attached to this drug concept.
cGMP: complaints of crystals not redissolving into solution after warming and shaking the vials. — Recalling firm: Eugia US LLC — Nationwide USA
cGMP - Water leakage — Recalling firm: SUN PHARMACEUTICAL INDUSTRIES INC — USA Nationwide
Lack of Assurance of Sterility: Manufacturing deviation which was reported due to a microbial excursion — Recalling firm: SUN PHARMACEUTICAL INDUSTRIES INC — Nationwide within the United States
CGMP Deviations: lots made with same active pharmaceutical ingredient (API) as lots that were rejected due to manufacturing issues that could cause the product to be out of specification for impurities. — Recalling firm: SUN PHARMACEUTICAL INDUSTRIES INC — Nationwide in the USA and Puerto Rico
CGMP Deviations: Manufacturing deviations were reported due to an abnormal appearance on parts of machinery. — Recalling firm: SUN PHARMACEUTICAL INDUSTRIES INC — nationwide.
Incorrect Labeling: Incorrect lot number on secondary packaging — Recalling firm: SUN PHARMACEUTICAL INDUSTRIES INC — Nationwide
cGMP Deviations; released lots were manufactured under similar manufacturing conditions to a previously rejected OOS Lot. — Recalling firm: Sun Pharmaceutical Industries, Inc. — Product was distributed throughout the United States.
cGMP Deviations; released lots were manufactured under similar manufacturing conditions to a previously rejected OOS Lot. — Recalling firm: Sun Pharmaceutical Industries, Inc. — Product was distributed throughout the United States.
Presence of Particulate Matter: organic and inorganic compounds detected in vials of product. — Recalling firm: Sun Pharmaceutical Industries, Inc. — Nationwide within the United States
Presence of Particulate Matter — Recalling firm: Sun Pharmaceutical Industries, Inc. — Nationwide